Literature DB >> 344114

beta-cell function in children with diabetes.

J Ludvigsson, L G Heding.   

Abstract

Although it is generally believed that insulin secretion is minimal or absent in juvenile-onset diabetes, we have found appreciable levels of C-peptide at the time of onset in 12 patients, 4 to 16 years old (9.3 +/- 4.2). Ten of them had ketonuria but none severe ketoacidosis. All entered a remission period. Most of the patients had near normal C-peptide levels during the remission, and their beta cells had the capacity to respond to a breakfast stimulation with increased insulin secretion. C-peptide and proinsulin were also determined in 98 juvenile diabetics with age at onset of 1 to 16 years (6.8 +/- 3.9) and a duration of diabetes between two and 17 years (6.7 +/- 3.4). Many were found to have persisting beta-cell function, which seems to be of importance for ensuring stability in metabolic control. Although little is known about factors that may slow or reverse the process leading to beta-cell failure, our results suggest that early detection and intensive treatment of diabetes before severe metabolic disturbances have occurred may help preserve beta-cell function.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 344114     DOI: 10.2337/diab.27.1.s230

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetes.

Authors:  Linda A DiMeglio; Peiyao Cheng; Roy W Beck; Craig Kollman; Katrina J Ruedy; Robert Slover; Tandy Aye; Stuart A Weinzimer; Andrew A Bremer; Bruce Buckingham
Journal:  Pediatr Diabetes       Date:  2015-02-27       Impact factor: 4.866

2.  The newer insulins.

Authors:  J G Devlin; O Maguire; V Parameswaran
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

3.  Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.

Authors:  M Wallensteen; G Dahlquist; B Persson; M Landin-Olsson; A Lernmark; G Sundkvist; B Thalme
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

Review 4.  The role of immunomodulation therapy in autoimmune diabetes.

Authors:  Johnny Ludvigsson
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

5.  The remission period in juvenile diabetes mellitus.

Authors:  O J Hensey; C S Smith
Journal:  Ir J Med Sci       Date:  1983-05       Impact factor: 1.568

6.  Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Authors:  S Madsbad
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

7.  The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.

Authors:  S Madsbad; T Krarup; O K Faber; C Binder; L Regeur
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

8.  Total glycosylated haemoglobin (HbA1) levels in diabetic children.

Authors:  N P Mann; D I Johnston
Journal:  Arch Dis Child       Date:  1982-06       Impact factor: 3.791

9.  Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.

Authors:  J Ludvigsson
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

10.  Type 1 (insulin-dependent) diabetes in Japanese children is not a uniform disease.

Authors:  T Urakami; Y Miyamoto; H Fujita; T Kitagawa
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.